Cavernous hemangioma of the spinal cord - Conservative or operative management?

Acta Neurologica Scandinavica

Volumn 114, Issue 4, 2006, Pages 287-290

  Kondziella, D ^a,b   Brodersen, P ^a   Laursen, H ^a   Hansen, K ^a  

^a Rigshospitalet   (Denmark)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bleeding; Cavernoma; Cavernous hemangioma; Conservative treatment; Operative excision; Spinal cord; Treatment options

Indexed keywords

ADULT; ANAMNESIS; CASE REPORT; CAVERNOUS HEMANGIOMA; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LAMINECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SPINAL CORD;

ADULT; BLOOD VESSELS; CEREBRAL CORTEX; FEMALE; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; NEUROSURGICAL PROCEDURES; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK ASSESSMENT; SPINAL CORD; SPINAL CORD DISEASES;

EID: 33748370984     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00675.x     Document Type: Review

References (18)

1. ROBINSON JR, AWAS IA, LITTLE JR. Natural history of the cavernous angioma. J Neurosurg 1991;75:709-14.
2. COSGROVE GR, BERTRAND G, FONTAINE S et al. Cavernous angiomas of the spinal cord. J Neurosurg 1988;68:31-6.
3. POLYMEROPOULOS MH, HURKO O, HSU F et al. Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descent. Neurology 1997;48:752-7.
4. ZHANG J, CLATTERBUCK RE, RIGAMONTI D et al. Mutations in KRIT1 in familial cerebral cavernous malformations. Neurosurgery 2000;46:1272-9.
5. DENIER C, GOUTAGNY S, LABAUGE P et al. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 2004;74:326-37.
6. RUSSEL D, RUBENSTEIN L. The pathology of tumours of the nervous system, 4th edn. London: Edward Arnold, 1977;126-45.
7. ZAMBRAMSKI J, HENN J, COONS S. Pathology of cerebral vascular malformations. Neurosurg Clin N Am 1999;10:395-410.
8. LABAUGE P, BRUNERAU L, LAVERGE S et al. Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformations. Neurology 2001;57:1825-8.
9. ZEVGARIDIS D, MEDELE RJ, HAMBURGER C et al. Cavernous haemangiomas of the spinal cord. A review of 117 cases. Acta Neurochir 1999;141:237-45.
10. WANG C, LIU A, ZHANG J et al. Surgical management of brain-stem cavernous malformations: report of 137 cases. Surg Neurol 2003;59:444-54.
11. PORTER RW, WILLINSKY RA, HARPER W et al. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg 1997;87:190-7.
12. FRIM DM, ZEC N, GOLDEN J et al. Immunohistochemically identifiable tissue plasminogen activator in cavernous angioma: mechanism for re-hemorrhage and lesion growth. Pediatr Neurosurg 1996;25:137-41.
13. ROTHBART D, AWAD IA, LEE J et al. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 1996;38:915-24.
14. VISHTEH AG, ZABRAMSKI JM, SPETZLER RF. Patients with spinal cord cavernous malformations are at an increased risk for multiple neuraxis cavernous malformations. Neurosurgery 1999;45:30-3.
15. ABDULRAUF SI, KAYNAR MY, AWAD IA. A comparison of the clinical profile of cavernousmalformations with and without associated venous malformations. Neurosurgery 1999;44:41-7.
16. VISHTEH AG, SANKHLA S, ANSON JA et al. Surgical resection of intramedullary spinal cord cavernous malformations: delayed complications, long-term outcomes and association with cryptic venous malformations. Neurosurg 1997;41:1094-100.
17. SANDALCIOGLU IE, WIEDEMAYER H, GASSER T et al. Intramedullary spinal cord cavernous malformations: clinical features and risk of hemorrhage. Neurosurg Rev 2003;26:253-6.
18. SANTORO A, PICCIRILLI M, FRATI A et al. Intramedullary spinal cord cavernous malformations: report of ten new cases. Neurosurg Rev 2004;27:93-8.